Brian Drachman

Statistics

Publications

Citations

H-Index

Active since

2024

Affiliations

Brian Drachman is an author at University of Pennsylvania specializing in drug design, pharmacokinetics of monoclonal antibodies, and pharmacokinetics.

ORCID

Publications per year

2024–2024

Publications

PRX004 in variant amyloid transthyretin (ATTRv) amyloidosis: results of a phase 1, open-label, dose-escalation study

Ole B. Suhr, Martha Grogan, Ana Silva et al. · Amyloid · 2024 · 38 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +11

Treatment characteristics of patients with hereditary transthyretin amyloidosis: a cohort study

Taha Qarni, Felipe J.S. Jones, Brian Drachman et al. · Orphanet Journal of Rare Diseases · 2024 · 11 citations · Full text

Life Sciences, Genetics, Pharmacotherapy +13

1–2 of 2